Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaques

Broadly neutralizing antibodies (bNAbs) targeting multiple sites of HIV-1 Env vulnerability can be induced by infection, but simultaneous elicitation of bNAbs against multiple epitopes has not been achieved by vaccination. In this study, we designed a dual-epitope vaccine targeting both the fusion peptide (FP) and the V2 apex and evaluated its capacity to induce bNAbs against both epitopes in rhesus macaques. This vaccine combined an FP conjugate with a cocktail of engineered Env trimers with enhanced V2 apex recognition and increased antigen retention in lymph nodes. Macaque immunization with the dual-epitope vaccine elicited >1,000-fold higher autologous tier 2-neutralizing titers than wild-type Env trimers and enhanced heterologous neutralization. Both FP- and V2 apex-monoclonal antibodies were isolated from immunized macaques and showed heterologous neutralization with genetic and structural signatures similar to well-characterized FP and V2 apex bNAbs. These results demonstrate proof of concept for simultaneous vaccine elicitation of neutralizing antibodies against multiple sites of Env vulnerability.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2026-01-29
DOI
https://doi.org/10.1016/j.celrep.2025.116905
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaques

Nicholas C. Morano, Madeeha Froze Mughal, Audrey S. Carson, G. J. Sellers et al.
Cell Reports
HIV Research and Treatment
article

Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaques

Nicholas C. Morano, Madeeha Froze Mughal, Audrey S. Carson, G. J. Sellers, Ninaad Lasrado, Andrea Biju, David J. Van Wazer, Chaim A. Schramm, Danealle K. Parchment, Tyler Stephens, Sarah Jane Smith, Misook Choe, Ryan S. Roark, Yaroslav Tsybovsky, Chen‐Hsiang Shen, Amy R. Henry, Jayeshbhai Chaudhari, Reda Rawi, Joseph P. Nkolola, Sijy J. O’Dell, Robin Carroll, J. P. M. Langedijk, Haijuan Du, Christy Lavine, Richard A. Koup, Lawrence Shapiro, Krisha McKee, Bette Korber, Hongying Duan, Daniel C. Douek, Nicole A. Doria-Rose, Shuishu Wang, Hua Wang, Peter D. Kwong, Lingshu Wang, Dan H. Barouch, John R. Mascola, Yongping Yang, Alejandro A. Espinosa Perez, I-Ting Teng, Jordan E. Becker, Cheng Cheng, Lucy Rutten, Baoshan Zhang
article en

Abstract

Broadly neutralizing antibodies (bNAbs) targeting multiple sites of HIV-1 Env vulnerability can be induced by infection, but simultaneous elicitation of bNAbs against multiple epitopes has not been achieved by vaccination. In this study, we designed a dual-epitope vaccine targeting both the fusion peptide (FP) and the V2 apex and evaluated its capacity to induce bNAbs against both epitopes in rhesus macaques. This vaccine combined an FP conjugate with a cocktail of engineered Env trimers with enhanced V2 apex recognition and increased antigen retention in lymph nodes. Macaque immunization with the dual-epitope vaccine elicited >1,000-fold higher autologous tier 2-neutralizing titers than wild-type Env trimers and enhanced heterologous neutralization. Both FP- and V2 apex-monoclonal antibodies were isolated from immunized macaques and showed heterologous neutralization with genetic and structural signatures similar to well-characterized FP and V2 apex bNAbs. These results demonstrate proof of concept for simultaneous vaccine elicitation of neutralizing antibodies against multiple sites of Env vulnerability.

Cell ReportsVol. 45(2)
Leidos (United States) (US), National Institutes of Health (US), Beth Israel Deaconess Medical Center (US), Aaron Diamond AIDS Research Center (US), New Mexico Consortium (US), National Institute of Allergy and Infectious Diseases (US), Janssen (Netherlands) (NL), Columbia University (US)
Good health and well-being
Openalex Percentile: Top 75%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.